Cost-effectiveness of vaccination against cervical cancer: a multi-regional analysis assessing the impact of vaccine characteristics and alternative vaccination …

E Suarez, JS Smith, FX Bosch, P Nieminen, CJ Chen… - Vaccine, 2008 - Elsevier
Mathematical models provide valuable insights into the public health and economic impact
of cervical cancer vaccination programmes. An in-depth economic analysis should explore …

Evolution of the health economics of cervical cancer vaccination

N Ferko, M Postma, S Gallivan, D Kruzikas… - Vaccine, 2008 - Elsevier
This paper reviews the history of modelling for cervical cancer vaccination. We provide an
interpretation and summary of conclusions pertaining to the usefulness of different models …

Optimization of primary and secondary cervical cancer prevention strategies in an era of cervical cancer vaccination: a multi-regional health economic analysis

RM Rogoza, N Ferko, J Bentley, CJLM Meijer… - Vaccine, 2008 - Elsevier
With the recent advent of cervical cancer vaccines, many questions relating to the best
overall prevention methods for cervical disease are beginning to arise. A Markov model was …

Comparison of detailed and succinct cohort modelling approaches in a multi-regional evaluation of cervical cancer vaccination

D Debicki, N Ferko, N Demarteau, S Gallivan, C Bauch… - Vaccine, 2008 - Elsevier
Mathematical models have been used extensively in the evaluation of chronic diseases and
in exploring the health economics of vaccination. In this study, we examine the value of …

Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries

L Colantonio, JA Gomez, N Demarteau, B Standaert… - Vaccine, 2009 - Elsevier
Implementation of cervical cancer (CC) vaccination in Latin America is expected to reduce
the high CC burden in those countries. But the efficiency of such vaccination programs in the …

[HTML][HTML] Cost-benefit analysis of vaccination: a comparative analysis of eight approaches for valuing changes to mortality and morbidity risks

M Park, M Jit, JT Wu - BMC medicine, 2018 - Springer
Background There is increasing interest in estimating the broader benefits of public health
interventions beyond those captured in traditional cost-utility analyses. Cost-benefit analysis …

Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA)

JJ Kim, M Sharma, M O'Shea, S Sweet, M Diaz… - Vaccine, 2013 - Elsevier
To date, no studies have evaluated the cost-effectiveness of human papillomavirus (HPV)
vaccination in countries in the Extended Middle East and North Africa (EMENA) region. We …

Present challenges in cervical cancer prevention: answers from cost-effectiveness analyses

M Diaz, S de Sanjosé, FX Bosch… - Reports of Practical …, 2018 - journals.viamedica.pl
Simulation models are commonly used to address important health policy issues that cannot
be explored through experimental studies. These models are especially useful to determine …

[HTML][HTML] A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancer

N Demarteau, B Detournay, B Tehard… - International journal of …, 2011 - Springer
Objective This study aimed at evaluating the cost-effectiveness of human papillomavirus
virus (HPV) vaccination in France, using a generally applicable succinct cohort model …

Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types

EP Armstrong - Journal of managed care pharmacy, 2010 - jmcp.org
BACKGROUND: Vaccines have demonstrated cost-effectiveness in managed care through
the prevention of disease. As new vaccines for previously untargeted conditions are …